Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness and Safety of Naporafenib Combinations in Patients with Previously Treated Unresectable or Metastatic Melanoma

    Not recruiting

    2 1 1
    Belgium France Germany Italy
  • Study on Continued Ceritinib Treatment for Patients with ALK Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Bulgaria France Germany Italy Poland
  • Study on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)

    Not recruiting

    3 1 1 1
    France Germany Italy The Netherlands Spain
  • Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium France Germany Greece Italy
  • Study of Letetresgene Autoleucel for Patients with Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    France Italy The Netherlands Spain
  • Long-Term Study of Tofacitinib for Children and Teens with Juvenile Idiopathic Arthritis

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    Belgium Poland Spain
  • Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    Denmark France Germany Italy Spain
  • Study on Ianalumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    3 1 1
    France Germany Italy Romania
  • Study on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Croatia Greece Hungary Italy Poland
  • Study of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    Czechia France Italy Spain